Home
- Questions About Raises, Shuttle Fees Top Administrators Forum
A UAMS Update article about Meet Your Administrator”
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Gruenwald Is New U.S. Citizen
Michael Gruenwald becomes U.S. citizen
- Doughnut Sale to Help UAMS Psychiatry Youth Program
A UAMS Update article about a bake sale
- Call-in Announcements, Forums Will Give Employees More Information
A UAMS Update article about plans to improve communication between administration and employees of UAMS Medical Center
- IT Help Desk 400,000th Call Sweepstakes
IT Help Desk 400,000th Call Sweepstates
- The UAMS Help Desk Today - Ten Years Later
The UAMS Help Desk Today - Ten Years Later
- Free Tickets for UAMS Nights at Ray Winder Field
A UAMS Update article about UAMS Night with the Travelers
- ARIA Training Sessions May 19 - June 27 at UAMS
A UAMS Update article about May 19 - June 27 training sessions
- Human Research Forum Is May 21
A UAMS Update article about human research Q & A
- Accolades, May 2003
Accolades to UAMS faculty and staff
- GCRC Deadline Changed to July 1 for Grant Proposals
A UAMS Update article about GCRC pilot grants
- History of the Help Desk
- Watch, Look & Listen: Preview of New UAMS Public Service Campaign
- Forum to Discuss Impact of HIPAA on Research
Update article about HIPAA and research at UAMS
- Human Research Q and A Forum June 27
A UAMS Update article about the human research forum
- Emailed Version of UAMS Notice of Privacy Practices
UAMS Notice of Privacy Practices
- Free UAF Symposium Aug. 14-15 on Evolution of Human Diet
A UAMS Update article about a diet symposium at UAF
- Tom Butler is Arkansas Administrator of the Year
Tom Butler of UAMS Is Arkansas Administrator of the Year
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
Join the Prostate Cancer Race Walk. Click Here for Registration Form.
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- Join UAMS/ACRC Team in Race for the Cure®!
Join UAMS/ACRC Team in Race for the Cure!
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
- Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
- Kids First in Fort Smith Celebrated Fourth in Style
Kids First in Fort Smith Celebrated Fourth in Style
- Class of 1948 Dedicates Endowment to Excellence in Education
Class of 1948 Dedicates Endowment to Excellence in Education
- Pharmacy Professor Elected to American College of Clinical Pharmacy
Pharmacy Professor Elected to American College of Clinical Pharmacy
- Pharmaceutical Scientists, Graduate Students Meet at UAMS
Pharmaceutical Scientists, Graduate Students Meet at UAMS
- Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
- New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
- Ready, Set, Go! UAMS, KATV Launch Get Healthy Arkansas™
UAMS, KATV Launch Get Healthy Arkansas™
- Breast Augmentation
Breast Augmentation
- Breast Augmentation
Breast Augmentation
- Healthy Foods for a Healthy Heart
Many women may be in danger of heart disease without even realizing they are. Fortunately, women can control some of the factors that contribute to heart disease
- Menopause and Estrogen Treatment
Frequently asked questions about treatment for menopause and estrogen treatment.
- Nutrition for Women
Women’s nutritional needs at each stage of life.
- Oral Health for Women
- Skin Care for Women
- Stress Management for Women
Stress Management and how to handle it.
- Related Sites
Links to related sites dealing with Women's Health Care
- Preventive Health Care for Women
- TIAA-CREF on Campus in February and March
TIAA-CREF on Campus in February and March
- TIAA-CREF on Campus in February and March
TIAA-CREF on Campus in February and March
- Human Resources Hosts 'HR Connects!' Feb. 16
Human Resources Hosts 'HR Connects!' Feb. 16
- Human Resources Hosts 'HR Connects!' Feb. 16
Human Resources Hosts 'HR Connects!' Feb. 16
- Arm protection System (APS) for robotic surgery: A surgical device to position the arms of surgical patients during prolonged robotic surgical procedures. (11-04)
A device to secure and position the arms of patients during prolonged surgical procedures to protect against nerve damage and assist the anesthesiologist access to IV sites.
- Arm protection System (APS) for robotic surgery: A surgical device to position the arms of surgical patients during prolonged robotic surgical procedures. (11-04)
A device to secure and position the arms of patients during prolonged surgical procedures to protect against nerve damage and assist the anesthesiologist access to IV sites.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
- Gray’s Anomaly: A Source of Empowerment
Feb. 8, 2012 | “I’ll trim it so it’s not so bulky,” James Y. Suen, M.D., said as he folded, then snipped a tiny edge of gauze off before he placed it on his patient’s right jaw. He has cared for 23-year-old Jasmine Gray ever since she was 11 when she traveled from Memphis, Tenn. to see him after first being misdiagnosed.
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Need Something Sweet for Your Valentine?
Need Something Sweet for Your Valentine?
- Code Moo Now Open
Code Moo Now Open
- Code Moo Now Open
Code Moo Now Open
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Sign Up for the UAMS House of Delegates Relay for Life Team
UAMS House of Delegates Relay for Life Team
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Overwhelming Response to SmartCare
Overwhelming Response to SmartCare
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Celebrating African American Women Firsts
Celebrating African American Women Firsts
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- Nutrition Department Hosts Food Drive
Nutrition Department Hosts Food Drive
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
- In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
|
Introduction
Clinical depression, or major depressive disorder, is a physical illness of the brain. There is much confusion about this illness because the term "depression" is often confused with the feeling of sadness. Actually, sadness is only one of many symptoms associated with this illness.
Depression can appear at any age. It is one of the most common and treatable of all mental illnesses. In any year, 9.6 million adults suffer from this physical disease. One in four women and one in 10 men can expect to develop it during their lifetime.
Women are more susceptible to depression than men for several reasons. Estrogen works in the brain like a mild antidepressant. As levels of estrogen decrease at various times throughout the life cycle, some women are at increased risk for depression:
- In the week or so prior to menstruation (premenstrual syndrome)
Following child birth (postpartum depression)
As the estrogen levels drop and menstrual cycles stop (perimenopausal depression) LI>
Many persons fail to recognize that they are suffering from depression and don’t get treatment. More than half of the persons who have had one episode of major depression will have another at some point in their lives.
Many underlying medical illnesses and conditions cause depression. In these circumstances, the official diagnosis is mood disorder due to a general medical condition. Conditions that can cause depression include:
- Endocrine or metabolic or disease: Thyroid disease, parathyroid disease, diabetes, Cushing’s, Addison’s, kidney failure on dialysis
- Vitamin deficiency: B12 deficiency
- Side effects of medication: Steroids, interferon, some chemotherapy agents
- Substance Induced: Alcohol, opiates or narcotics, amphetamine, cocaine
- Cancer: Pancreatic, lung, gastrointestinal and cancers spread to the brain (lung, breast, metastatic melanoma, kidney)
- HIV (Human immunodeficiency virus, the virus that causes AIDS)
- AIDS (Aquired immune deficiency syndrome)
- Autoimmune disorder: Lupus
- Brain injury or illness: Parkinson’s, Huntington’s, stroke, multiple sclerosis, epilepsy
Depression underlies the majority of suicides, is the eighth leading cause of death, and is the third leading cause of death among persons aged 15-24.
Symptoms of Depression
Nearly everyone with this illness has lasting feelings of sadness. They may feel helpless, hopeless, and irritable. A person who experiences four or more of the following symptoms for more than two weeks should seek professional help.
- Noticeable change of appetite
- Noticeable change of sleeping patterns
- Loss of interest in activities formerly enjoyed
- Loss of energy, feeling of fatigue
- Feelings of worthlessness
- Persistent feelings of hopelessness
- Feelings of inappropriate guilt
- Inability to concentrate or think; indecisiveness
- Recurring thoughts of death or suicide
- Melancholia, defined as overwhelming feelings of sadness and grief, accompanied by waking at least two hours earlier than normal in the morning
- Disturbed thinking; beliefs not based on reality
- Physical symptoms (headaches or stomach aches)
Treatment of Depression
It is important to recognize and treat depression. Recently, it has been discovered that major depression as a risk factor for stroke is equivalent to a 40 point increase in systolic blood pressure! The risk of death and complication for depressed individuals with heart disease is increased at least threefold over non-depressed individuals with the same severity of heart disease.
There is a link between infertility and depression. In addition, it has been associated with poor fetal growth and pre-maturity. Depressed pregnant women are at risk for suicide, not caring for themselves adequately, poor nutrition, inadequate sleep and self-medication with drugs, alcohol and tobacco. Depressed mothers have difficulty interacting with their newborns, resulting in slower cognitive development by the baby and less affection between mother and baby.
The risk-benefit ratio of treatment versus non-treatment during pregnancy and lactation must always be taken into account when determining whether to treat a pregnant woman for depression. There are, of course, no controlled studies of antidepressants during pregnancy. Many pharmaceutical companies have unpublished information regarding the safety and efficacy of their medication in pregnant women. The largest data set is kept by the maker of Prozac (Eli Lilly, Inc.) as it is the oldest SSRI. A recent prospective study showed that other selective serotonin reuptake inhibitors (SSRIs) fluvoxamine, paroxetine, and sertraline do not appear to increase the teratogenic risk (birth defects) when used in their recommended doses. Many studies are currently in progress, and the data should appear in the literature in the next few years.
Most depressions are treated with combinations of medication and psychotherapy. Antidepressant medications begin to lift a depression approximately two weeks after daily use. The longer the depression went without treatment, the longer it takes to completely lift. Once an individual feels back to herself, it is important to continue the course of antidepressants for nine to 12 months in order to have the best chance of avoiding relapse. Medication should be decreased slowly, with the woman and her doctor watching for a re-emergence of depressive symptoms. Patients with more than two episodes of depression may require a maintenance medication long term.
Mild levels of depression have been noted to respond to St. John’s Wort, an over the counter non-FDA approved formulation. Recent dangerous drug interactions have been noted with St. John’s as it increases the rate of break down of critical medications (those to fight HIV, to prevent heart transplant rejection and birth control pills). St. John’s Wort has not been found to be safe in pregnancy. Be certain to tell your physician and pharmacist if you are planning to take St. John’s Wort.
Psychotherapy can be used for milder forms of depression and in combination with medication for more severe cases. Psychotherapy involves talking with a trained professional. The therapist’s aim, depending upon the type of therapy, is to help the patient gain insights about herself and thus change thoughts, feelings, and behavior that may contribute to depression. Some studies have shown that cognitive behavioral therapy and interpersonal therapy are as effective as medication for mild to moderate depression.
Electroconvulsive therapy (ECT) is very effective for treating patients who cannot take certain medications due to a heart condition, pregnancy, old age or severe malnourishment, and for patients who are suicidal or who do not respond to antidepressants. Before ECT is administered, patients receive anesthesia and a muscle relaxant to protect them from physical harm and pain. Side effects tend to be brief.
A subtype of depression called seasonal affective disorder results from some people’s sensitivity to seasonal changes in the amount of available daylight. Studies have shown that spending a period of time each day under a "light box" that emits full-spectrum light is an effective treatment.
Should traditional treatment methods be ineffective, keep searching for an unrecognized cause in your life for the depression. In summary, never accept a life of suffering with the emotional pain of depression. Help exists!
Linda L.M. Worley, M.D., is an associate professor of psychiatry and behavioral sciences at the University of Arkansas for Medical Sciences and a fellow in the Academy of Psychosomatic Medicine. She also is medical director of the UAMS General Hospital Psychiatry Service, Student Mental Health and Arkansas CARES.
Related Site American Psychiatric Association: www.psych.org
Top of Page
|